Filing Flows

Filing Flows › Rayonier (RYN) › Stock forecast & fair value

Rayonier (RYN) stock forecast and fair value

Rayonier (RYN) trades at $21.55. 6 analysts' median price target is $22.50 (+4%), from $19.00 to $30.00. Across 24 valuation methods the middle fair value is $12.05 (-44%).

Price$21.55
Median target$22.50
Fair value, middle$12.05
EPS beat rate100%
Rayonier fair value by method (price $21.55)Rayonier fair value by method (price $21.55)low – highpoint estimateP/E vs peers$6.84P/E vs peers, weighted$9.19P/E vs peers, growth-adjusted$5.39EV/EBITDA vs peers$3.56EV/EBITDA vs peers, weighted$5.96EV/Sales vs peers$17.97EV/Sales vs peers, weighted$25.76EV/Sales vs peers, growth & margin …$6.89Residual income$16.00P/FFO vs REIT peers$9.45

Fair value by method

MethodLowPointHighvs price
P/E vs peers$4.98$6.84$9.25-68%
P/E vs peers, weighted$6.54$9.19$18.50-57%
P/E vs peers, growth-adjusted$3.27$5.39$8.88-75%
EV/EBITDA vs peers$1.67$3.56$5.92-83%
EV/EBITDA vs peers, weighted$3.63$5.96$8.35-72%
EV/Sales vs peers$5.29$17.97$24.97-17%
EV/Sales vs peers, weighted$17.70$25.76$31.74+20%
EV/Sales vs peers, growth & margin adjusted$3.38$6.89$11.82-68%
Residual income$15.41$16.00$16.63-26%
P/FFO vs REIT peers$7.99$9.45$13.06-56%

Rayonier's latest quarter

Rayonier, Q2 2026: revenue $396M (+272% year over year), operating margin 8.7%, net earnings $19.1M, operating cash flow $111M. The chart follows the revenue to costs, profit and cash.

Questions

What is the price target for RYN stock?

The median of 6 analysts' 12-month targets is $22.50, +4% from $21.55; the range is $19.00 to $30.00. The average rating is none.

What is Rayonier's fair value?

The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $3.56 and $67.12, with a middle value of $12.05 against a price of $21.55. Each method's assumptions are on the page.

Does Rayonier usually beat earnings estimates?

It beat the consensus EPS estimate in 100% of the quarters on record.

Is RYN stock a buy?

Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.